|
|
|||||||||||||||||||||||||||||
INC Research Buyback
OLI recorded this information on 8/16/2016
Intercure is engaged in the medical cannabis sector. Co. has two direct subsidiaries, Canndoc Ltd. (Canndoc) and Cannolam Ltd. (Cannolam). Canndoc's operations are focused on the production (including the breeding, cultivating, importing and processing), manufacturing, exporting and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use. Cannolam's operations are focused on establishing and operating dedicated pharmacies for the distribution of pharmaceutical-grade cannabis under the brand name Givol, including a Cookies-branded location.
Open the INCR Page at The Online Investor (in a new window) »
|
|